Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SUMATRIPTAN Cause Product availability issue? 23 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Product availability issue have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.1% of all adverse event reports for SUMATRIPTAN.

23
Reports of Product availability issue with SUMATRIPTAN
0.1%
of all SUMATRIPTAN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product availability issue From SUMATRIPTAN?

Of the 23 reports, 2 (8.7%) required hospitalization.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does SUMATRIPTAN Cause?

Drug ineffective (2,941) Product physical issue (2,349) Application site erythema (1,875) Drug dose omission (1,711) Product quality issue (1,269) Application site pain (1,217) Migraine (978) Headache (914) Product complaint (718) Nausea (702)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which SUMATRIPTAN Alternatives Have Lower Product availability issue Risk?

SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN SUMATRIPTAN vs SUMAVEL DOSEPRO SUMATRIPTAN vs SUNITINIB SUMATRIPTAN vs SUNITINIB MALATE SUMATRIPTAN vs SUTENT

Related Pages

SUMATRIPTAN Full Profile All Product availability issue Reports All Drugs Causing Product availability issue SUMATRIPTAN Demographics